These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26010541)

  • 1. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
    Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
    PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2.
    Bilousova T; Elias C; Miyoshi E; Alam MP; Zhu C; Campagna J; Vadivel K; Jagodzinska B; Gylys KH; John V
    Biochem Biophys Res Commun; 2018 May; 499(4):751-757. PubMed ID: 29604274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.
    Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J
    J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
    Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
    Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model.
    Zhu C; Bilousova T; Focht S; Jun M; Elias CJ; Melnik M; Chandra S; Campagna J; Cohn W; Hatami A; Spilman P; Gylys KH; John V
    Mol Brain; 2021 Apr; 14(1):70. PubMed ID: 33875010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Synaptosomal-Associated Protein 25 with Neutral Sphingomyelinase 2: Functional Impact on the Sphingomyelin Pathway.
    Won JH; Jeon HJ; Kim SK; Shin IC; Jang JM; Ha HC; Back MJ; Kim DK
    Neuroscience; 2020 Feb; 427():1-15. PubMed ID: 31765623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide induction.
    Meyers-Needham M; Lewis JA; Gencer S; Sentelle RD; Saddoughi SA; Clarke CJ; Hannun YA; Norell H; da Palma TM; Nishimura M; Kraveka JM; Khavandgar Z; Murshed M; Cevik MO; Ogretmen B
    Mol Cancer Ther; 2012 May; 11(5):1092-102. PubMed ID: 22452947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.
    Marchesini N; Osta W; Bielawski J; Luberto C; Obeid LM; Hannun YA
    J Biol Chem; 2004 Jun; 279(24):25101-11. PubMed ID: 15051724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sirtuin inhibitor cambinol reduces intracellular glucosylceramide with ceramide accumulation by inhibiting glucosylceramide synthase.
    Ishibashi Y; Ito M; Hirabayashi Y
    Biosci Biotechnol Biochem; 2020 Nov; 84(11):2264-2272. PubMed ID: 32705968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
    Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
    Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress.
    Cubí R; Candalija A; Ortega A; Gil C; Aguilera J
    PLoS One; 2013; 8(6):e68055. PubMed ID: 23826362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Robust Liposomal Platform for Direct Colorimetric Detection of Sphingomyelinase Enzyme and Inhibitors.
    Holme MN; Rana S; Barriga HMG; Kauscher U; Brooks NJ; Stevens MM
    ACS Nano; 2018 Aug; 12(8):8197-8207. PubMed ID: 30080036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
    Qin J; Kilkus J; Dawson G
    Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of neutral sphingomyelinase 2 from bovine brain and its calcium-dependent activation.
    Kim SK; Ahn KH; Jeon HJ; Lee DH; Jung SY; Jung KM; Kim DK
    J Neurochem; 2010 Feb; 112(4):1088-97. PubMed ID: 19968763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease.
    Šála M; Hollinger KR; Thomas AG; Dash RP; Tallon C; Veeravalli V; Lovell L; Kögler M; Hřebabecký H; Procházková E; Nešuta O; Donoghue A; Lam J; Rais R; Rojas C; Slusher BS; Nencka R
    J Med Chem; 2020 Jun; 63(11):6028-6056. PubMed ID: 32298582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutral sphingomyelinases and nSMase2: bridging the gaps.
    Clarke CJ; Hannun YA
    Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock.
    Lugrin J; Ciarlo E; Santos A; Grandmaison G; dos Santos I; Le Roy D; Roger T
    Biochim Biophys Acta; 2013 Jun; 1833(6):1498-510. PubMed ID: 23499872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.
    Barth BM; Gustafson SJ; Kuhn TB
    J Neurosci Res; 2012 Jan; 90(1):229-42. PubMed ID: 21932365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.
    Tallon C; Picciolini S; Yoo SW; Thomas AG; Pal A; Alt J; Carlomagno C; Gualerzi A; Rais R; Haughey NJ; Bedoni M; Slusher BS
    Biochem Pharmacol; 2021 Dec; 194():114796. PubMed ID: 34678224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.
    Airola MV; Shanbhogue P; Shamseddine AA; Guja KE; Senkal CE; Maini R; Bartke N; Wu BX; Obeid LM; Garcia-Diaz M; Hannun YA
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5549-E5558. PubMed ID: 28652336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.